Oramed up big in early trading

• Thinly-traded nano cap Oramed Pharmaceuticals (ORMP +57.3%) jumps on whopping 26x surge in volume, albeit on turnover of 1.2M shares. No particular news accounts for the move.
• The company is developing an oral insulin, ORMD-0801, for the treatment of type 1 and type 2 diabetes.
• Shares have been in a funk for a while, bottoming at $4.31 on December 30, down 86% from the peak of $31.73 on January 13, 2014.